Since CD123 was also found to be highly expressed on CD34+CD38− LSCs in blast crisis and chronic phase CML patients compared to healthy donors, these cells were targetable in CML patients. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.